Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
ACS Biomaterials Science & Engineering
|
November 17, 2021
Implantable and Degradable Thermoplastic Elastomer
Allison Siehr, Craig Flory, Trenton Callaway, et al.
Arthritis and Rheumatism
|
June 10, 2003
In vivo selective inhibition of mitogen-activated protein kinase kinase 1/2 in rabbit experimental osteoarthritis is associated with a reduction in the development of structural changes
Jean-Pierre Pelletier, Julio C Fernandes, Julie Brunet, et al.
Arthritis and Rheumatism
|
February 5, 2005
Oral treatment with PD-0200347, an alpha2delta ligand, reduces the development of experimental osteoarthritis by inhibiting metalloproteinases and inducible nitric oxide synthase gene expression and synthesis in cartilage chondrocytes
Christelle Boileau, Johanne Martel-Pelletier, Julie Brunet, et al.
Annals of the Rheumatic Diseases
|
June 6, 2009
Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis
Astrid Jüngel, Caroline Ospelt, Mark Lesch, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 19, 2025
Preclinical quality, safety, and efficacy of a CGMP iPSC-derived myogenic progenitor product for the treatment of muscular dystrophies
Karim Azzag, Alessandro Magli, James Kiley, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
ACS Biomaterials Science & Engineering
|
November 17, 2021
Implantable and Degradable Thermoplastic Elastomer
Allison Siehr, Craig Flory, Trenton Callaway, et al.
Arthritis and Rheumatism
|
June 10, 2003
In vivo selective inhibition of mitogen-activated protein kinase kinase 1/2 in rabbit experimental osteoarthritis is associated with a reduction in the development of structural changes
Jean-Pierre Pelletier, Julio C Fernandes, Julie Brunet, et al.
Arthritis and Rheumatism
|
February 5, 2005
Oral treatment with PD-0200347, an alpha2delta ligand, reduces the development of experimental osteoarthritis by inhibiting metalloproteinases and inducible nitric oxide synthase gene expression and synthesis in cartilage chondrocytes
Christelle Boileau, Johanne Martel-Pelletier, Julie Brunet, et al.
Annals of the Rheumatic Diseases
|
June 6, 2009
Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis
Astrid Jüngel, Caroline Ospelt, Mark Lesch, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 19, 2025
Preclinical quality, safety, and efficacy of a CGMP iPSC-derived myogenic progenitor product for the treatment of muscular dystrophies
Karim Azzag, Alessandro Magli, James Kiley, et al.
Page
of 1